Furthermore, glioma patients with high CD99 expression exhibited resistance to chemotherapy and radiotherapy, and a positive correlation was found between increased CD99 levels and poor short-term recurrence and survival [115]. This evidence concerns the gene CD99 and central nervous system cancer.